banner

Investors

At Acadia, we remain deeply committed to providing important new therapies to patients and delivering value for our stockholders. Our Investor Center is designed to provide you with convenient access to company information.

Recent News

05/05/21
- 1Q21 net sales of $106.6 million , an 18% increase over 1Q20 - Reiterating FY21 net sales guidance of $510 to $550 million SAN DIEGO --(BUSINESS WIRE)--May 5, 2021-- Acadia Pharmaceuticals Inc. (Nasdaq: ACAD), today announced its financial results for the first quarter ended March 31, 2021 .
05/04/21
SAN DIEGO --(BUSINESS WIRE)--May 4, 2021-- Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate at the following investor conferences: BofA Securities 2021 Health Care Conference Fireside Chat Presentation: Wednesday, May 12, 2021 at 2:45 p.m.
04/21/21
Company to host conference call and webcast on Wednesday, May 5, 2021 , at 5:00 p.m. Eastern Time SAN DIEGO --(BUSINESS WIRE)--Apr. 21, 2021-- Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report first quarter 2021 financial results on Wednesday, May 5, 2021 , after the
Webcasts

05/05/21 at 5:00 PM EDT

05/12/21 at 2:45 PM EDT

Acadia Pharmaceuticals at the RBC Capital Markets Global Healthcare Conference
05/18/21 at 3:05 PM EDT